Results: Acute Lymphoblastic Leukaemia

Results from Abstracts

Pick one of the followings

*Some genes may be words of complete meaning. In any case, if present, they are relevant key words.

Legend:

***	p-value <= 0.001
**	p-value <= 0.01
*	p-value <= 0.05
n.s.	not significant

Top Ranked Genes, Molecules or Short Names*

Efs ***
Bcr ***
Runx1 **
Tpmt **
Cd19 *
Etv6 *
Sct *
Ikzf1 *
Abl1 *
Cd34 *
Poldip3 *
Notch1 *
Ptpro *
Cbfa2t2 *
Btg1 *
Cd52 *
Nup214 *
Hdac8 *
Add3 *
Mthfd1 *
Ccr7 *
Mthfr *
Ldb1 *
Cr1 *
Phf6 *
Amn *
Cd5 *
Bcl2l11 *
Gmps *
Ncor1 *
Cd22 *
Cr2 *
Eed n.s.
Dhfr n.s.
Pgr n.s.
Smc1a n.s.
Fhit n.s.
Mcl1 n.s.
Tlx3 n.s.
Rag2 n.s.
Pax5 n.s.
Grp n.s.
She n.s.
Hr n.s.
Crlf2 n.s.
Ep300 n.s.
Fbxw7 n.s.
Asns n.s.
Cd38 n.s.
Hdac1 n.s.
Cd27 n.s.
Stil n.s.
Pdc n.s.
P2ry8 n.s.
Rela n.s.
Cd7 n.s.
Flt3 n.s.
Syk n.s.
Gata1 n.s.
Gstm1 n.s.
Bid n.s.
Preb n.s.
Cd79a n.s.
Slc19a1 n.s.
Wt1 n.s.
Jak1 n.s.
Nudt15 n.s.
Aga n.s.
Slco1b1 n.s.
Cd28 n.s.
Cd33 n.s.
Mut n.s.
Jak2 n.s.
Gata3 n.s.
Abcb1 n.s.
Foxp3 n.s.
Kdm6a n.s.
Ebf1 n.s.
Tal1 n.s.
Ctgf n.s.
Lmo2 n.s.
Cdkn2a n.s.
Arid5b n.s.
Mcc n.s.
Cd1a n.s.
Itpa n.s.
Gstp1 n.s.
Cxcr4 n.s.
Kmt2a n.s.
Nrm n.s.
Inpp5d n.s.
Cd300a n.s.
Pecam1 n.s.
Casd1 n.s.
Erg n.s.
Hoxd13 n.s.
Gimap5 n.s.
Lyl1 n.s.
Gzma n.s.
Gzmb n.s.

Top Ranked Key Phrases

B cell acute lymphoblastic leukaemia ***
T cell acute lymphoblastic leukaemia ***
Allogeneic stem cell transplantation ***
White blood cell count ***
Minimal residual disease mrd ***
Refractory acute lymphoblastic leukaemia ***
Paediatric acute lymphoblastic leukaemia ***
Chronic myeloid leukaemia cml ***
Childhood acute lymphoblastic leukaemia ***
Acute myeloid leukaemia aml ***
Childhood acute lymphoblastic leukemia ***
Chronic lymphocytic leukaemia cll ***
Event free survival efs ***
Adult acute lymphoblastic leukaemia ***
Relapsed acute lymphoblastic leukaemia ***
Minimal residual disease ***
Tyrosine kinase inhibitors ***
Acute lymphoblastic leukaemia ***
B cell precursor ***
Acute myeloid leukaemia ***
Chronic myeloid leukaemia ***
Acute lymphoblastic leukemia ***
Bone marrow bm ***
Event free survival ***
Disease free survival ***
B cell malignancies ***
Bone marrow samples **
Non hodgkin lymphoma **
Long term survivors **
Long term follow **
High income countries **
Overall survival os **
Health related quality **
Cochrane central register **
High risk patients *
Bcr abl *
Childhood cancer survivors *
Bone marrow *
B cell *
Precursor b *
Acute leukaemia *
T cell *
Pre b *
B lineage *
Cell lines *
Peripheral blood *
Inotuzumab ozogamicin *
National institute n.s.
Human t n.s.
Odds ratios n.s.
Acute leukaemias n.s.
Non hodgkin n.s.
Leukaemia cells n.s.
Tel aml1 n.s.
Odds ratio n.s.
Cell death n.s.
Dna methylation n.s.
Cell cycle n.s.
T cells n.s.
Childhood leukaemia n.s.
Mll rearranged n.s.
Cell proliferation n.s.
Adrenal insufficiency n.s.
Protein levels n.s.
Risk factor n.s.
S lymphoma n.s.
Life threatening n.s.
Cranial irradiation n.s.
Complete remission n.s.
Leukaemic cells n.s.
Single centre n.s.
Tumour cells n.s.
L asparaginase n.s.
Significantly higher n.s.
Controlled trials n.s.
High levels n.s.
Significantly lower n.s.
Flow cytometry n.s.
S disease n.s.
Hodgkin lymphoma n.s.
Survival rates n.s.
Newly diagnosed n.s.
Physical activity n.s.
Tpmt activity n.s.
Malignant cells n.s.
Metabolic syndrome n.s.
High risk n.s.
Was diagnosed n.s.
Study was n.s.
Adverse events n.s.
Notch signalling n.s.
Allo sct n.s.
Was associated n.s.
Multivariate analysis n.s.
Blast cells n.s.
Patient was n.s.
5 year survival n.s.

Top Ranked Mesh Terms

Apoptosis ***
Female ***
Acute disease ***
Recurrence ***
Risk assessment ***
Daunorubicin ***
Oncogene proteins fusion ***
Precursor cell lymphoblastic leukemia-lymphoma ***
Philadelphia chromosome ***
Neoplasms ***
Middle aged ***
Neoplasm proteins ***
Vincristine ***
Antineoplastic agents ***
Retrospective studies ***
Hematologic neoplasms ***
Combined modality therapy ***
Antifungal agents ***
Prognosis ***
Polymorphism single nucleotide ***
Remission induction ***
Prospective studies ***
Fatal outcome ***
Follow-up studies ***
Adolescent ***
Mutation ***
Epidemiology ***
Neoplasm residual ***
Case-control studies ***
Leukemia myeloid acute ***
Oligonucleotide array sequence analysis ***
Disease-free survival ***
Infant newborn ***
Gene expression regulation leukemic ***
Infant ***
Genetics ***
Aged ***
Diagnosis ***
Immunophenotyping ***
Precursor b-cell lymphoblastic leukemia-lymphoma ***
Mice ***
Hematopoietic stem cell transplantation ***
Dexamethasone ***
Age factors ***
Methods ***
Precursor t-cell lymphoblastic leukemia-lymphoma ***
Reverse transcriptase polymerase chain reaction ***
Gene expression profiling ***
Antineoplastic combined chemotherapy protocols ***
Genotype ***
Survival analysis ***
Cell line tumor ***
Pharmacology ***
Child preschool ***
Male ***
Biomarkers tumor ***
Incidence ***
Risk factors ***
Animals ***
Methotrexate ***
Survival rate ***
Asparaginase ***
Immunocompromised host ***
Mortality ***
Signal transduction ***
Tumor cells cultured ***
Prednisone ***
Aged 80 and over ***
Leukemia ***
Drug resistance neoplasm ***
Adult ***
Registries ***
Pathology ***
Transplantation homologous ***
United kingdom ***
Antimetabolites antineoplastic ***
Child ***
Treatment outcome ***
Blood ***
Humans ***
Gene expression regulation neoplastic ***
Metabolism ***
Dose-response relationship drug ***
Flow cytometry ***
Young adult ***
Randomized controlled trials as topic ***
In situ hybridization fluorescence ***
Time factors ***
Translocation genetic ***
Cell proliferation ***
Drug therapy ***
Bone marrow transplantation ***
Leukemia myelogenous chronic bcr-abl positive ***
Clinical trials as topic ***
Polymerase chain reaction ***
Survivors ***
Protein kinase inhibitors ***
Quality of life ***
Kaplan-meier estimate ***
Cohort studies ***

Top Ranked Mesh Terms (Symptoms)

Translocation genetic ***
Philadelphia chromosome ***
Acute disease ***
Neoplasm residual ***
Recurrence ***
Neoplasm recurrence local ***
Genetic predisposition to disease ***
Chromosome aberrations **
Disease progression **
Cell transformation neoplastic **
Pain *
Osteonecrosis *
Bacteremia *
Polyuria *
Obesity *
Leukemic infiltration *
Abscess *
Fever *
Paraparesis *
Nausea *
Candidemia *
Purpura *
Abnormal karyotype *
Sensation disorders *
Musculoskeletal pain *
Arthralgia *
Epistaxis *
Chromosome deletion *
Necrosis *
Fungemia *
Weight loss *
Gastrointestinal hemorrhage *
Disease susceptibility *
Neovascularization pathologic *
Sepsis *
Neoplasm invasiveness n.s.
Blast crisis n.s.
Chronic disease n.s.
Abdominal pain n.s.
Hepatomegaly n.s.
Birth weight n.s.
Carcinogenesis n.s.
Chromosome breakage n.s.
Aneuploidy n.s.
Leukocytosis n.s.
Splenomegaly n.s.
Purpura thrombocytopenic idiopathic n.s.
Cross infection n.s.
Jaundice n.s.
Neoplasm metastasis n.s.
Overweight n.s.
Hemorrhage n.s.
Body weight n.s.
Proteinuria n.s.
Postoperative complications n.s.
Vomiting n.s.
Trisomy n.s.
Intracranial hemorrhages n.s.
Fatigue n.s.
Cicatrix n.s.
Chromosomal instability n.s.
Polydipsia n.s.
Hearing disorders n.s.
Sarcopenia n.s.
Prodromal symptoms n.s.
Atrioventricular block n.s.
Thinness n.s.
Paresthesia n.s.
Extravasation of diagnostic and therapeutic materials n.s.
Growth disorders n.s.
Genomic instability n.s.
Gait disorders neurologic n.s.
Vascular fistula n.s.
Melena n.s.
Intestinal fistula n.s.
Parasitemia n.s.
Emphysema n.s.
Sleep wake disorders n.s.
Language disorders n.s.
Back pain n.s.
Ring chromosomes n.s.
Disease n.s.
Iatrogenic disease n.s.
Encephalocele n.s.
Triploidy n.s.
Constipation n.s.
Arrhythmias cardiac n.s.
Muscle weakness n.s.
Hyperplasia n.s.
Memory disorders n.s.
Hematuria n.s.
Cell transformation viral n.s.
Paralysis n.s.
Urinary bladder neurogenic n.s.
Remission spontaneous n.s.
Cardiotoxicity n.s.
Blindness n.s.
Apraxias n.s.
Vitreous hemorrhage n.s.
Paresis n.s.

Results for: Acute Lymphoblastic Leukaemia

Results from Abstracts

KEGG Pathways

Gene Ontology Biological Processes